Advertisement

Topics

Companies Related to "A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy" [Most Relevant Company Matches] - Page: 3 RSS

16:26 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy" found in our extensive corporate database of over 50,000 company records.

Showing "Study Assess Safety Dose Conversion Dose Individualization Duragesic" Companies 51–75 of 2,200+

Relevant

Creative Compounds

Creative Compounds is a compounding-only pharmacy that was started in January of 1998. Our goal is to improve the health of our patients by working with them and their practitioners to come up with custom medications that improve therapeutic outcomes. We custom make the proper dose into a dosage form that is best for each patient.


Avant Immunotherapeutics

AVANT Immunotherapeutics, Inc. is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease. The company is developing a broad portfolio of vaccines against viral and bacterial diseases, including single-dose oral vaccines aimed a protecting travelers from cholera, typhoid fever and other illnesses. In addition, the co...

GENETWORx, LLC

Our mission is to deliver meaningful Personalized Medicine results to patients, providing health care professionals the necessary tools to leverage their knowledge and truly individualize treatment plans based on a patient’s DNA – Utilizing the latest technology in DNA sequencing to help provide the right medications, at the right dose, and effec...


CivaTech Oncology Inc.

CivaTech Oncology Inc. develops improved low dose rate (LDR) brachytherapy devices. Our first device, the CivaString™, has been cleared by the FDA for use in localized tumors. The Company is also developing innovative implantable bioabsorbable brachytherapy products for the treatment of breast, lung and other cancers.

BioTime, Inc. and Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics, Inc. is a leading biotechnology company in the emerging field of regenerative medicine. The company’s proprietary, industry leading platforms are based on its pluripotent stem cell and dendritic cell immunotherapy technologies. Asterias is focused on developing therapies to treat conditions in several medical areas where ther...

ZymeQuest Incorporated

ZymeQuest, a development stage company, is the global leader in the discovery, development and commercialization of enzymatic blood conversion products for use in blood transfusion medicine. Our enzymatic blood conversion system enables the precise and permanent conversion of groups A, B and AB red blood cells to enzyme converted group O red blood cells, known as ECO red cells. ECO red cells are f...

Colorcon, Inc.

Colorcon is a world leader in the development, supply and technical support of formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical industry. Our best-in-class products and technologies are complemented by our value-added services, which support all phases of solid oral dose design and development.

TIESRx

TIESRx™ developed the Treatment Advantage™ with the goal of improving patient outcomes via: (1) increasing patient persistency by addressing discontinuation threats with behavior-based technology innovation; (2) improving patient compliance by supporting full dose on-time adherence; and (3) capturing real-time patient reported outcome measurements.

Riverain Medical

Riverain Medical is a Dayton, Ohio based medical technology innovator that develops practical solutions to save and improve the quality of people’s lives, through the early detection of disease. The company’s technologies are designed to enhance the expert skills of physicians to improve patient outcomes without additional radiation dose or proce...

CSL Biotherapies

CSL Biotherapies has an initial contract worth $180 million to deliver bulk H1N1 vaccine antigen to the U.S. Health and Human Services Department (HHS), with an option for filling and packaging services out of CSL’s Kankakee, Illinois and Marburg, Germany facilities. These facilities have the capability to produce seasonal and pandemic influenza vacci...

Pharma Two B Ltd.

Pharma Two B develops clinically differentiated and value-added products, based on approved drugs. The company focuses on Fixed-Dose-combinations of two or more drugs with complementary and synergistic effects, providing high clinical value and shorter regulatory pathways (US 505(b)(2) approach). The company develops products in two therapeutic areas with ...

Targeted Medical Pharma, Inc.

Physician Therapeutics is a division of Targeted Medical Pharma, Inc., a specialty pharmaceutical company that develops and sells prescription medical foods to physicians, pharmacies and skilled nursing facilities for the treatment of pain syndromes, obesity, sleep and cognitive disorders. Based in Los Angeles, the company’s proprietary pharmac...

MEPS Real-Time Inc.

Founded in 2006 and headquartered in Carlsbad, Calif., MEPS Real-Time, Inc. (mepsrealtime.com) is a leading provider of Radio Frequency Identification (RFID) solutions for pharmacy automation and inventory management. Its suite of Intelliguard® RFID Management Systems offer unprecedented real-time visibility of high-value, critical-dose pharmaceutical i...

Gofire

Gofire™ is a digital healthcare company developing a proprietary smart inhaler with a personal dosing app that allows patients to re-create consistent experiences, removing the fear of taking too much while having the support of their community to help find products best suited to specific ailments. Gofire is committed to making alternative health acc...

Priority Pharmacy

Whether you want the convenience of having routine medications delivered reliably to your doorstep - or have special on-going maintenance needs - we're focused on you. We do all your insurance paperwork, and work directly with doctors to make sure refills are authorized when you need them. Do you have long-term or special needs? Priority Pharmacy features free customized programs ensuring your dru...

Mystic Pharmaceuticals, Inc.

Mystic Pharmaceuticals™ is an integrated specialty pharmaceutical company based in Austin, Texas. Mystic provides precision unit dose delivery systems for pharmaceuticals and biologics for ophthalmic and system intranasal applications. Mystic partners with pharmaceutical and biotech manufacturers to combine its novel delivery systems with a pipeline o...

Pharnext SAS

Pharnext is an advanced clinical stage biopharmaceutical company founded by renowned scientists and entrepreneurs including Professor Daniel Cohen, a pioneer in modern genomics. Pharnext focuses on neurodegenerative diseases and has two lead products in clinical development: PXT3003 is currently in an international Phase 3 trial for the treatment of Charco...

Advanced Pain Remedies

Headquartered near Research Triangle Park, NC, APR is majority owned and virtually run by Cato BioVentures. APR will work with Advanced Targeting Systems, Cato Research and Cato BioVentures to develop and seek a partner to commercialize SP-SAP as a novel, non-opioid treatment for severe chronic pain. This technology is a single dose, microsurgery which is anticipated to have minimal adverse side e...

Riverain Technologies

Riverain Technologies, formerly Riverain Medical, is a Dayton, Ohio-based medical technology innovator that develops practical solutions to save and improve the quality of people’s lives through the early detection of disease. The company’s technologies are designed to enhance the expert skills of radiologists to improve patient outcomes without ...

Collegium Pharmaceutical Inc.

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patent protected DETERx® formulation platform for the treatment of chronic pain. The DETERx oral drug delivery technology provides extended release delivery, unique tamper resistant properties, and flexible dose adminis...

Kedalion Therapeutics, Inc.

Kedalion Therapeutics is a venture-backed, clinical-stage biotechnology company whose mission is to bring to market transformative topical ophthalmic therapies for new and existing indications. Kedalion’s proprietary AcuStream platform technology delivers topical drugs to the eye in a precise and accurate manner that enables comparable effect with up ...

Sunny Pharmtech Inc.

Sunny Pharmtech Inc. is an emerging specialty pharmaceutical company based in Taiwan and was founded in 2004 with a focus on the development of technically difficult products. In 2014, the capability of developing and producing active pharmaceutical ingredients was added. The resulting organization is now fully-integrated, doing research, development, and ...

Vaxin Inc.

Vaxin Inc. is a clinical stage biotechnology company, founded in December 1997 with facilities in Rockville, MD and Birmingham, AL, developing next generation vaccines to address significant public health and biodefense needs. Vaxin is focused on vaccines designed to protect people against influenza and anthrax infection using proprietary, patented technol...

Wavelength Pharmaceuticals

Wavelength is a leading developer and manufacturer of generic APIs and finished dose forms (“FDF”) with operations primarily located in Israel. Wavelength supports a global, blue-chip customer base and has a broad array of products that leverage its specialized manufacturing capabilities (including cytotoxic, steroid and high potency) and core co...

KineMed Inc.

KineMed, Inc. ("KineMed" or the "Company") is a drug discovery and development company employing its proprietary translational medicine technology (AquaTag™ and KineMarker™) to both identify active drug candidates preclinically and confirm their therapeutic activity and dose response in first-in-man studies. The Company is working to develop drug...


More From BioPortfolio on "A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks